Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era (SCOPE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by University of California, San Francisco
Sponsor:
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00187512
First received: September 13, 2005
Last updated: May 5, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: March 2019 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):